A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- Vasa Therapeutics
- Study ID
- NCT07219511
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Heart
- Heart Failure With Preserved Ejection Fraction (HFPEF)
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- VS-041 — DRUGVS-041 high dose, VS-041 low dose or Placebo tablet BID
- Placebo — OTHERPlacebo to match VS-041
Study Details
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Key Dates
- Start date
- Nov 4, 2025
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 42 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Placebo
- Experimental: Low Dose VS-041
- Experimental: High Dose VS-041
Primary Outcome Measure
Participant incidence of treatment-emergent adverse events (TEAEs) [ Time Frame: From Baseline to Day 28 ]
Central Contacts
- Clinical Team760-230-3398
Locations (21)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cardiology and Medicine Clinic | Little Rock | Arkansas | 72204 | - |
| National Institute of Clinical Research | Huntington Beach | California | 92648 | - |
| FOMAT | Santa Maria | California | 93454 | - |
| Invivocure LLC | Van Nuys | California | 91405 | - |
| New Generation of Medical Research | Hialeah | Florida | 33016 | - |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | - |
| Amavita Health | North Miami Beach | Florida | 33169 | - |
| Broward Research Center | Pembroke Pines | Florida | 33024 | - |
| Eagle Clinical Research | Chicago | Illinois | 60621 | - |
| Chicago Medical Research | Hazel Crest | Illinois | 60429 | - |
| Methodist Medical Center of Illinois | Peoria | Illinois | 61606 | - |
| Louisiana Heart Center | Slidell | Louisiana | 70458 | - |
| Washington University | St Louis | Missouri | 63110 | - |
| Ash Research Clinic | Brick | New Jersey | 08724 | - |
| Erie County Medical Center | Buffalo | New York | 14215 | - |
| Duke University Medical Center | Durham | North Carolina | 27710 | - |
| Wake Forest | Winston-Salem | North Carolina | 27157 | - |
| Cleveland Clinic | Cleveland | Ohio | 44195 | - |
| Oklahoma Heart Hospital | Oklahoma City | Oklahoma | 73120 | - |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75231 | - |
| LinQ Research, LLC | Tomball | Texas | 77375 | - |
Find similar trials in Little Rock, AR
Related Studies
- Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEFRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Transfusion Requirements in Younger Patients Undergoing Cardiac SurgeryRecruiting · Unity Health Toronto · Portland, Maine
- Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)PHASE1 · Recruiting · Secretome Therapeutics · Chicago, Illinois
- ELEVATE-HFpEF Clinical StudyRecruiting · Medtronic Cardiac Rhythm and Heart Failure · Phoenix, Arizona